Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > I think we should do a 5-10M volume day July 4
View:
Post by livermore2 on Jul 01, 2022 1:37pm

I think we should do a 5-10M volume day July 4

What do you all think? Wouldn't take much if all us longs did an add day!

Once the volume comes - look out - all in my own opinion!
Comment by livermore2 on Jul 01, 2022 1:42pm
Having a cure for cancer should not be held back the way we are. Good luck longs, frustrating as it's been with our share performance with such great results to date!!!
Comment by 99942Apophis on Jul 01, 2022 2:16pm
livermore2 wrote Having a cure for cancer should not be held back the way we are. Good luck longs, frustrating as it's been with our share performance with such great results to date!!! Most of us here believe that to be true. People that haven't bought yet look at it and see the first 12 got the incorrect dose, they see problems within the company as the founding father being slapped ...more  
Comment by Rumpl3StiltSkin on Jul 01, 2022 2:26pm
Yep Just a cpl more news releases...  Soo close. 
Comment by johannn on Jul 01, 2022 8:22pm
Yup, and the average Joe, is still buying after almost 12 years......Nocturne in E-flat Major, Op. 9, No. 2 (Frdric Chopin | Vadim Chaimovich) - YouTube   Once you get to be as old as I am...you just hope it will be here in time........lol
Comment by Impalaman on Jul 02, 2022 8:17am
With the US markets closed---I don't think SSSSOOOOWWWW.
Comment by stocksnbonds458 on Jul 02, 2022 2:26pm
We longs already own most of the company, I suppose a little more wont hurt
Comment by toade1313 on Jul 04, 2022 2:03pm
We're almost there!!! 6,100 so far and 2hrs to go.
Comment by Pandora on Jul 04, 2022 2:34pm
10K at this point. Must have been a typo on the "M" -- no one could be that far off on a realistic guess.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250